Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Nacu, Serban ^a   Yuan, Wenlin ^a   Kan, Zhengyan ^a   Bhatt, Deepali ^a   Rivers, Celina Sanchez ^a   Stinson, Jeremy ^a   Peters, Brock A ^a   Modrusan, Zora ^a   Jung, Kenneth ^a   Seshagiri, Somasekar ^a   Wu, Thomas D ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZGP1 GJC3 FUSION PROTEIN; BAHD1 ISOVALERYL COENZYME A DEHYDROGENASE FUSION PROTEIN; BCAS3 BCAS4 FUSION PROTEIN; BETA MICROSEMINOPROTEIN NCOA4 FUSION PROTEIN; CP110 TMC5 FUSION PROTEIN; ENTPD5 FAM161B FUSION PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYBRID PROTEIN; INSULIN RECEPTOR SUBSTRATE 2 NUPIP1 FUSION PROTEIN; KLK11 STRATUM CORNEUM CHYMOTRYPTIC ENZYME FUSION PROTEIN; MRPS28 TPD52 FUSION PROTEIN; TRANSCRIPTION FACTOR ELK 4 SLC45A3 FUSION PROTEIN; TRANSCRIPTION FACTOR ERG TMPRSS2 FUSION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CHIMERA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EXON; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE FUSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOMAL FRAMESHIFTING; RNA SEQUENCE; RNA SPLICING; RNA TRANSCRIPTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; ADENOCARCINOMA; COMPARATIVE STUDY; GENETIC DATABASE; GENETICS; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; STANDARD;

ADENOCARCINOMA; BASE SEQUENCE; COMPARATIVE GENOMIC HYBRIDIZATION; DATABASES, GENETIC; EXPRESSED SEQUENCE TAGS; GENE FUSION; HUMANS; MALE; PROSTATIC NEOPLASMS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA;

EID: 78751650428     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-11     Document Type: Article

References (55)

1. Magrangeas F, Pitiot G, Dubois S, Bragado-Nilsson E, Cheérel M, Lebeau SJB, Boisteau O, Lethé B, Mallet J, Jacques Y, Minvielle S: Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor α-chain genes generate a fusion mRNA in normal cells. Journal of Biological Chemistry 1998, 273:16005-16010. (Pubitemid 28311367)
2. Thomson TM, Lozano JJ, Loukili N, Carrió R, Serras F, Courmand B, Valeri M, Diaz VM, Abril J, Burset M, Merino J, Macaya A, Corominas M, Guigó R: Fusion of the human gene for the polyubiquitination coeffector UEV1 with Kua, a newly identified gene. Genome Research 2000, 10:1743-1756.
3. Communi D, Suarez-Huerta N, Dussossoy D, Savi P, Boeynaems JM: Cotranscription and intergenic splicing of human P2Y11 and SSF1 genes. Journal of Biological Chemistry 2001, 276:16561-16566.
4. Pradet-Balade B, Medema JP, Lopez-Fraga M, Lozano JC, Kolfschoten GM, Picard A, Martinez AC, Garcia-Sanz JA, Hahne M: An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. The EMBO Journal 2002, 21:5711-5720. (Pubitemid 35315271)
5. Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R, Novik A, Sorek R: Transcription-mediated gene fusion in the human genome. Genome Research 2006, 16:30-36. (Pubitemid 43048931)
6. Parra G, Reymond A, Dabbouseh N, Dermitzakis ET, Castelo R, Thomson TM, Antonarakis SE, Guigo R: Tandem chimerism as a means to increase protein complexity in the human genome. Genome Research 2006, 16:37-44. (Pubitemid 43048932)
7. Kowalski PE, Freeman JD, Mager DL: Intergenic splicing between a HERVH endogenous retrovirus and two adjacent human genes. Genomics 1999, 57:371-379.
8. Kato M, Khan S, Gonzalez N, O'Neill BP, McDonald KJ, Cooper BJ, Angel NZ, Hart DNJ: Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1. Journal of Biological Chemistry 2003, 278:34035-34041. (Pubitemid 37553240)
9. Brooks YS, Wang G, Yang Z, Smith KK, Bieberich E, Ko L: Functional pre-mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation. Journal of Biological Chemistry 2009, 284:18033-18046.
10. Wang K, Ubriaco G, Sutherland LC: RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours. BMC Genomics 2007, 8:348.
11. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM: Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101.
12. Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA: SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcription prostate cancer. Cancer Research 2009, 69:2734-2738.
13. Kapranov P, Drenkow J, Cheng J, Long J, Helt G, Dike S, Gingeras TR: Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Research 2005, 15:987-997. (Pubitemid 40994219)
14. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J, Alioto T, Manzano C, Chrast J, Dike S, Wyss C, Henrichsen CN, Holroyd N, Dickson MC, Taylor R, Hance Z, Foissac S, Myers RM, Rogers J, Hubbard T, Harrow J, Guigó R, Gingeras TR, Antonarakis SE, Reymond A: Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Research 2007, 17:746-759. (Pubitemid 46919711)
15. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nature Reviews Genetics 2009, 10:57-63.
16. Levin JZ, Berger MF, Adiconis X, Rogov P, Melnikov A, Fennell T, Nusbaum C, Garraway LA, Gnirke A: Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biology 2009, 10:R115.
17. Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette TR, Grasso C, Yu J, Lonigro RJ, Scroth G, Kumar-Sinha C, Chinnaiyan A: Chimeric transcript discovery by paired-end transcriptome sequencing. Proc National Acad Sci 2009, 106:12353-12358.
18. Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald TY, Cao X, Barrette T, Tewari AK, Chee MS, Chinnaiyan AM, Rickman DS, Demichelis F, Gerstein MB, Rubin MA: Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Research 2011, 21:56-67.
19. Sboner A, Habegger L, Pflueger D, Terry S, Chen DZ, Rozowsky JS, Tewari AK, Kitabayashi N, Moss BJ, Chee MS, Demichelis F, Rubin MA, Gerstein MB: FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biology 2010, 11:R104.
20. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB: Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476. (Pubitemid 352759009)
21. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ: Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics 2008, 40:1413-1415.
22. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, Scherf M, Seifert M, Borodina T, Soldatov A, Parkhomchuk D, Schmidt D, O'Keefe S, Haas S, Vingron M, Lehrach H, Yaspo ML: A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321:956-960.
23. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulker GJ, Brown MK, Taylor DF, Steptoe AL, Wani S, Bethel G, Robertson AJ, Perkins AC, Bruce SJ, Lee CC, Ranade SS, Peckman HE, Manning JM, McKernan KJ, Grimmond SM: Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nature Methods 2008, 5:613-619. (Pubitemid 351911866)
24. Bona FD, Ossowski S, Schneeberger K, Ratsch G: Optimal spliced alignments of short sequence reads. Bioinformatics 2008, 24:i174-180.
25. Trapnell C, Pachter L, Salzberg SL: TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
26. Ameur A, Wetterborm A, Feuk L, Gyllensten U: Global and unbiased detection of splice junctions from RNA-Seq data. Genome Biology 2010, 11:R34.
27. Wu TD, Nacu S: Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010, 26:873-881.
28. Wu TD, Watanabe CK: GMAP: a genomic mapping and alignment program for mRNA and EST sequences. Bioinformatics 2005, 21:1859-1975.
29. Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C, Hunkapiller K, Jensen RV, Knight CR, Lee KY, Ma Y, Maqsodi B, Papallo A, Peters EH, Poulter K, Ruppel PL, Samaha RR, Shi L, Yang W, Zhang L, Goodsaid FM: Evaluation of DNA microarray results with quantitative gene expression platforms. Nature Biotechnology 2006, 24:1115-1122. (Pubitemid 44359723)
30. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, et al: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnology 2006, 24:1151-1161. (Pubitemid 44359727)
31. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648. (Pubitemid 41528150)
32. Li H, Wang J, Mor G, Sklar J: A neoplastic gene fusion mimics transsplicing of RNAs in normal human cells. Science 2008, 321:1357-1361.
33. Thierry-Mieg D, Thierry-Mieg J: AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biology 2006, 7(Suppl 1):S12.
34. Lewis BP, Green RE, Brenner SE: Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings ofthe National Academy ofSciences 2003, 100:189-192. (Pubitemid 36078050)
35. Chang YF, Imam JS, Wilkinson MF: The nonsense-mediated decay RNA surveillance pathway. Annaul Review ofBiochemistry 2007, 76:51-74.
36. Clark J, Merson S, Jhavar S, Flohr P, Edwards S, Foster CS, Edes R, Martin FL, Phillips DH, Crundwell M, Christmas T, Thomopson A, Fisher C, Kovacs G, Cooper CS: Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene 2007, 26:2667-2673. (Pubitemid 46632014)
37. Mojica WD, Stein L, Hawthorn L: Universal reference RNA is not a representative normal sample for oligonucleotide microarray studies. Pathol Oncol Res 2008, 14:241-251.
38. Kwaśnicka-Crowford DA, Carson AR, Scherer SW: IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. Biochemical and Biophysical Research Communications 2006, 350:890-899. (Pubitemid 44584177)
39. Wang J, Cai Y, Ren C, Ittmann M: Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Research 2006, 66:8347-8351. (Pubitemid 44449142)
40. Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J: TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Research 2006, 66:10658-10663. (Pubitemid 44876959)
41. Skotheim RI, Thomassen GOS, Eken M, Lind GE, Micci F, Ribeiro FR, Cerveira N, Teixeira MR, Heim S, Rognes T, Lothe RA: A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Molecular Cancer 2009, 8:5.
42. Lin C, Yang L, Tanasa B, Hutt K, gun Ju B, Ohgi KA, Zhang J, Rose DW, Fu XD, Glass CK, Rosenfeld MG: Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
43. Menon R, Omenn GS: Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. Cancer Research 2010, 70:3440-3449.
44. Venables JP: Aberrant and alternative splicing in cancer. Cancer Research 2004, 64:7647-7654.
45. Eeles RA, Kote-Jarai Z, Giles GG, Al Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamorniert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Dnoovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Behr-Swain BN, Wilkonson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, The UK Genetic Prostate Cancer Study Collaborators, The British Association of Urological Surgeons' Section of Oncology, The UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF: Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genetics 2008, 40:316-321.
46. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hayes RB, Hunter DJ, Chanock SJ: Multiple loci identified in a genomewide association study of prostate cancer. Nature Genetics 2008, 310-315. (Pubitemid 351311773)
47. Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C: Reducing the agonist activity of antiandrogens in a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells. Journal of Biological Chemistry 2003, 278:19619-19626. (Pubitemid 36799145)
48. Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature 2009, 458:719-724.
49. Wang XS, Prensner JR, Chen G, Cao Q, Han B, Dhanasekaran SM, Ponnala R, Cao X, Varambally S, Thomas DG, Giordano TJ, Beer DG, Palanisamy N, Sartor MA, Omenn GS, Chinnaiyan AM: An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer. Nature Biotechnology 2009, 27:1005-1011.
50. Sonnhammer ELL, Eddy SR, Durbin R: Pfam: A comprehensive database of protein domain families based on seed alignments. Proteins: Structure, Function, and Bioinformatics 1997, 28:405-420. (Pubitemid 27280344)
51. Pospisil H, Herrmann A, Butherus K, Pirson S, Reich J, Kemmner W: Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNBB1 and LRP5) and altered Axin-1 expression during tumour progression. BMC Genomics 2006, 7:148.
52. Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 2002, 30:207-210. (Pubitemid 34679544)
53. Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A: Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes, Chromosomes and Cancer 2002, 35:311-317. (Pubitemid 35246989)
54. Ruan Y, Ooi HS, Choo SW, Chiu KP, Zhao XD, Srinivasan KG, Yao F, Choo CY, Liu J, Ariyaratne P, Bin WGW, Kuznetsov VA, Shahab A, Sung WK, Bourque G, Palanisamy N, Wei CL: Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Research 2007, 17:828-838. (Pubitemid 46919718)
55. Hampton OA, Hollander PD, Miller CA, Delgado DA, Li J, Coarfa C, Harris RA, Richards S, Scherer SE, Muzny DM, Gibbs RA, Lee AV, Milosavljevic A: A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Research 2009, 19:167-177.